as having diabetic cardiomyopathy (ie, adverse changes in cardiac structure and function). However, most previous studies have only performed limited measures of cardiac structure and function, and none have comprehensively evaluated cardiac parameters, particularly diastolic function with echocardiographic 2-dimensional (2D) imaging, pulse, and tissue Doppler. Only MESA (Multi-Ethnic Study of Atherosclerosis) has published results, suggesting that the mechanisms linking T2DM and cardiac structure and function might be different across race/ethnicity-specifically, left ventricular mass (LVM), end-diastolic volume (EDV), and stroke volume. 6 However, in MESA, several Hispanic/ Latino heritage subgroups are under-represented (eg, Cuban Americans), and the MESA protocol did not assess diastolic function. In addition, beyond the role of diabetic cardiomyopathy in HF development, it is unclear whether elevated, yet clinically normal, levels of T2DM risk biomarkers, such as glycosylated hemoglobin (HbA1c), fasting glucose, or insulin resistance, are related to cardiac structure and function among diabetes mellitus-free participants.
ECHO-SOL (Echocardiographic Study of Latinos), an echocardiographic ancillary study of the HCHS/SOL (Hispanic Community Health Study/Study of Latinos), is a multicenter epidemiological study designed to include a diverse Hispanic/Latino subgroup representation and provide a unique opportunity to explore the role of abnormal glucose metabolism across the spectrum of glycemic homeostasis in relation to clinical and preclinical markers of cardiac structure and function.
Methods
The HCHS/SOL is a multicenter community-based cohort study of Hispanics/Latinos in the United States designed to examine chronic disease risk factors and related longitudinal morbidity and mortality. 7, 8 Participants were recruited from 4 US communities (Bronx, NY; Chicago, IL; Miami, FL; and San Diego, CA) using a probability sample design.
ECHO-SOL is an echocardiographic ancillary study of the HCHS/ SOL with the previously described methodology. 9 In brief, 1818 participants were enrolled using a stratified random sampling design to ensure that a balanced number of participants representative of the overall HCHS/SOL were enrolled at each center. Participants were eligible for ECHO-SOL if they were aged ≥45 years; self-identified as Cuban, Mexican, Puerto Rican, Dominican, Central American, or South American; and were within 36 months from their initial HCHS/ SOL visit. The Institutional Review Board at the Wake Forest School of Medicine and at each study site provided approval and oversight of all study materials and activities. All ECHO-SOL participants gave informed consent.
In-Person Examination
The HCHS/SOL examination protocol has been previously published. 10 Participants were examined after an overnight, minimum 8-hour fast during which participants were asked to only consume water and necessary medications. Height (cm) and weight (kg) were measured, and body mass index was calculated as weight/height. 2 Seated resting blood pressures were measured in triplicate, and the average of the second and third readings was used for analysis. Fasting blood glucose was measured from plasma using a hexokinase enzymatic method (Roche Diagnostics, Indianapolis, IN), and fasting insulin was assessed using a hexokinase enzymatic method (Roche Diagnostics Corporation).
11 HbA1c was measured from whole blood with a Tosoh G7 Automated HPLC Analyzer (Tosoh Bioscience).
Echocardiographic Protocol
A Philips IE-33 or Sonos 5500/7500 ultrasound imaging platform was used across all the field imaging centers. 9 Trained sonographers performed echocardiography examinations, including M-mode, 2D imaging with harmonics optimizing depth, and sector to maintain a high frame rate, spectral Doppler. Color flow and tissue Doppler were performed by experienced sonographers at each field imaging center as per American Society of Echocardiography recommendations. 12, 13 The following echocardiographic measured and derived variables were used: LVM was determined by subtracting the LV endocardial cavity volume from the LV epicardial volume and multiplying the resultant myocardial volume by the myocardial density (1.05 g/mL) then indexing based on the body surface area or height 2.7 . LV geometry was predicated on the measurement of LVM, LV posterior wall thickness at diastole (LVPWd), interventricular septal thickness at diastole, and relative wall thickness (RWT) defined as 2×(LVPWd/LV internal diameter at diastole). Abnormal LVM and RWT were defined as >125 and ≥0.42 g/m 2 , respectively. LV geometry was defined as normal (normal LVM and normal RWT) or abnormal with abnormal LV geometry categorized as follows: concentric remodeling (normal LVM and increased RWT), eccentric hypertrophy (increased LVM and normal RWT), and concentric hypertrophy (increased LVM and increased RWT). 13 Our assessment of left ventricular diastolic dysfunction (LVDD) has been previously published 14 and focused on (1) pulse-wave Doppler performed in the apical 4-chamber view with the sample volume placed in the mitral valve orifice at the level of the leaflet tips to obtain peak early and late diastolic transmitral inflow velocities, (2) tissue Doppler imaging to acquire mitral early diastolic (E′) annular velocities from the apical 4-chamber view (the average of septal and lateral annular velocities was used), (3) left atrial volume measured in biplane views indexed to body surface area, and (4) pulsed-wave Doppler used for interrogation of pulmonary venous flow systolic and diastolic inflow velocities. The grading scheme for DD was grade I (mild), grade II (moderate), or grade III (severe), incorporating the previously published definitions using a combination of published American Society of Echocardiography and Redfield definitions.
12,15 LV stiffness was characterized by considering the end-diastolic pressure-volume relationship using the previously developed methods to predict the EDV at 20 mm Hg (EDV20), 16 where decreasing values denote an increasing LV stiffness. To characterize systolic function, left ventricular ejection fraction (LVEF) was derived from volumetric assessments using the biplane method of disks, 17 using the apical 4-and 2-chamber long-axis views to measure EDV and end-systolic volume (ESV), and the LVEF is calculated as follows: LVEF=(EDV−ESV)/EDV.
Echocardiograms were analyzed and interpreted centrally at Wake Forest School of Medicine (Winston-Salem, NC). All ECHO-SOL echocardiograms were read by a certified technical reader and over-read by a board-certified cardiologist with expertise in echocardiography (C.J.R.) with Core Cardiovascular Training Statement level 3 advanced training in Echocardiography and American Society of Echocardiography Board Certification in Comprehensive Adult Echocardiography. Inter-reader reliability studies have been performed, and intraclass correlations were >0.80 for all measures, 9, 14 indicating strong agreement.
Diabetes Mellitus and Insulin Resistance Classification
Diabetes mellitus status was classified based on the American Diabetes Association criteria 11 : either fasting plasma glucose ≥126 mg/dL (7 mmol/L), 2-hour postload glucose (2-hour oral glucose tolerance test) ≥200 mg/dL (11.2 mmol/L), and HbA1c ≥6.5% (48 mmol/mol) or documented hypoglycemic use (scanned medications). No information was available to distinguish between T1DM and T2DM. The American Diabetes Association goal for HbA1c level of <7.0% (53 mmol/mol) was used to define glycemic control. Prediabetes was defined as HbA1c ≥5.7 but <6.5% in the absence of treatment. Insulin resistance was calculated as insulin in µU/mL×glucose in mmol/L per 22.5 according to the homeostatic model assessment for insulin resistance (HOMA-IR), 18 and participants were categorized into HOMA-IR quintiles. Glucose Regulation and Cardiac Structure and Function
Statistical Analysis
All analyses were conducted using SAS version 9.4. SAS SURVEY procedures, and sampling weights were used to account for the complex survey design. 7, 8, 19 Several analyses were performed to examine the associations between 3 primary exposures (diabetes mellitus status, diabetes mellitus control, or HOMA-IR quintiles) and the aforementioned echocardiographic outcomes. First, distributions of the potential confounders of the relationship between diabetes mellitus and cardiac structure and function were summarized. Age-standardized (2010 census) diabetes mellitus prevalence was estimated using the PROC DESCRIPT via SAS callable SUDAAN release 11.
11
In separate multivariable linear regressions, the mean levels of continuous echocardiographic outcomes were regressed across categories of diabetes mellitus status, diabetes mellitus control, or HOMA-IR quintiles. Adjusted mean values of select outcomes are presented across exposure categories, and reported P values are based on the F statistics. For binary outcomes under the study, multivariable logistic regression was used to model the log odds of the outcome according to the diabetes mellitus status. Odds ratios (95% confidence intervals) are presented. Multivariable adjusted prevalence estimates for LVDD were derived by converting the log odds obtain in logistic regression to probabilities.
We present results from crude and multivariable statistical models to inform the strength and direction of possible confounding by age, sex, study site, tobacco use (never/former/current), alcohol use (never/former/current), physical activity levels (low/moderate/high, based on self-report 14 ), body mass index, hypertension (blood pressure medication or systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg), and chronic kidney disease (estimatedglomerular filtration rate<60 mL/min per 1.73 m 2 ). Glomerular filtration rate was estimated from serum creatinine according to the National Institute for Diabetes and Digestive and Kidney Diseases guidelines and the chronic kidney disease epidemiology collaboration equation. Models including income and education adjustments were also considered but had no meaningful influence on the results and were removed to enhance parsimony and precision.
The scaling used in figures is based on the clinically meaningful ranges. Zero was not included in the scale because values of zero are not biologically plausible for any of our echocardiographic outcomes.
Results
The average age for the ECHO-SOL target population was 56 years with 57% female. The proportion of self-identifying as Data are presented as mean±SEM or n (%) using weighted row percentages; n presented are unweighted counts of total participants in the HCHS/SOL with respective characteristic. It is HCHS/SOL publication policy to present weighted percentages, but unweighted percentages can be calculated based on the unweighted n presented. The number of participants with missing data for select variables are summarized as follows: renal disease, n=5; body mass index (BMI), n=1; alcohol use, n=1; cigarette use, n=2; health insurance, n=20; educational status, n=39; income, n=131; LAVI, n=37; E′<8 cm/s, n=10; E/E′ ratio>10, n=21; diastolic dysfunction, n=32. eGFR indicates estimatedglomerular filtration rate; HCHS/SOL, Hispanic Community Health Study/Study of Latinos; LAVI, left atrial volume index; and LV, left ventricle.
*Chronic kidney disease defined by eGFR <60 mL/min and National Institute for Diabetes and Digestive and Kidney Diseases criteria.
†Defined via Framingham Cardiovascular Disease composite criteria. Table 1 and Tables I through III in the Data Supplement. The prevalence of diabetes mellitus in the ECHO-SOL population was 28% (53% controlled and 47% uncontrolled), whereas prediabetes prevalence was 42%. The age-standardized prevalence of diabetes mellitus was 29% (30% versus 28% in men versus women). The overall mean HbA1c level was 6.06±0.04%, and mean HbA1c values among individuals who were diabetes mellitus free, had prediabetes, controlled diabetes mellitus, and uncontrolled diabetes mellitus were 5.3±0.02%, 5.8±0.02%, 6.2±0.03%, and 8.7±0.15%, respectively. Median (25th, 75th percentile) HOMA-IR values across quintiles of HOMA-IR were 1.0 (0.9, 1.2), 1.8 (1.6, 1.9), 2.5 (2.3, 2.7), 3.6 (3.3, 4.1), and 6.7 (5.4, 9.7), respectively. Prevalence of increased LV hypertrophy was 26%, abnormal LV geometry 45%, systolic dysfunction 3.6%, and DD (grades I-III) was 61%.
Relationship Between Prediabetes, Diabetes Mellitus, and Cardiac Structure and Function
In multivariable analysis adjusted for the aforementioned cardiometabolic risk factors, glycemic status was not associated with LVM, although several individual indices of LVM (LVPWd, interventricular septal thickness at diastole) were elevated in diabetes mellitus versus diabetes mellitus-free individuals (all P<0.05; Table 2 ). LV geometry differed significantly by diabetes mellitus status with higher RWT and more prevalent abnormal LV geometry among diabetes mellitus versus diabetes mellitus-free individuals (Table 2; Figure I in the Data Supplement). EF and LV stroke volume were significantly reduced among individuals with diabetes mellitus when compared with diabetes mellitus-free individuals. E/E′ lateral ratio was elevated in prediabetes and diabetes mellitus by ≈5% and 7%, respectively, whereas lateral and medial peak E′ velocities were both decreased by a similar degree (all P<0.001). Prediabetes and diabetes mellitus were associated with a 1.36-fold 
Relationship Between Diabetes Mellitus Control and Cardiac Structure and Function
LVM was significantly higher among those with uncontrolled versus controlled diabetes mellitus. LVPWd, interventricular septal thickness at diastole, and RWT were all higher in uncontrolled versus controlled diabetes mellitus (Table 3) . EF was modestly but significantly decreased in uncontrolled versus controlled diabetes mellitus (P=0.002; 
Relationship Between Insulin Resistance and Cardiac Structure and Function
Interventricular septal thickness at diastole and RWT values all increased across quintiles of HOMA-IR (P<0.001; Figure 1 ). Trends were similar for LVPWd, and adjusted mean±SE values were 0.87±0.02, 0.86±0.01, 0.88±0.02, 0.88±0.01, and (Figure 2A ), although there tended to be a nonlinear decreasing trend for EF (P for any difference=0.07; Figure 2A ) with the highest EF observed in quintile 2; only the EFs in quintiles, Q4 and Q5, were statistically significantly different than in Q2 (P<0.04 and P<0.005, respectively). EDV and ESV decreased by ≈13% and ≈10%, respectively, when comparing Q5 versus Q1 of HOMA-IR (P<0.05; Figure 2B and 2C). Increased levels of HOMA-IR were not associated with E/E′ lateral ratios but were associated with a modest increase in E/E′ septal ratio ( Figure 3A ). In contrast, both lateral and medial peak E′ wave velocities decreased with an increasing insulin resistance (both P<0.01; Figure 3B ). The odds of LVDD among individuals in Q2 or Q3 of HOMA-IR (versus Q1) were ≈1.0, whereas Q4 and Q5 odds ratios were both 1.34 (P for any difference=0.24). Figure 3C shows the prevalence of DD across HOMA-IR quintiles, which increased by 13% between the Q1 and Q5 (P=0.057). EDV20 was reduced by 14% when comparing with Q5 versus Q1 of HOMA-IR (P<0.0001; Figure 3D) . Additional tabular results for HOMA-IR are presented in Table V in the Data Supplement. Analyses for the HOMA-IR exposure were conducted in subgroups of individuals with and without diabetes mellitus, and the overall trends were not meaningfully changed (data not shown).
Discussion
In a large diverse sample of Hispanic/Latino men and women living in the United States, we investigated the association between both impaired glucose regulation and insulin resistance and comprehensive measures of cardiac structure and systolic and diastolic function. Both insulin resistance and dysglycemia (across the spectrum from prediabetes to uncontrolled diabetes mellitus) were associated with several outcomes but most consistently with E/E′ lateral and septal ratios and lateral and medial peak E′ velocities. These findings advance the robust literature on the cardiac abnormalities in diabetes mellitus (a.k.a., diabetic cardiomyopathy) 4, 6, [20] [21] [22] [23] in valuable ways. First, we perform a robust characterization of cardiac structure and function beyond just LVM and LVEF, including several measures of diastolic function. Second, we include diabetes mellitus-free individuals and investigate elevated but clinically normal glucose levels and insulin resistance (2 prominent metabolic abnormalities in diabetogenesis). This feature expands the concept of diabetic cardiomyopathy by demonstrating that the relationships emerge before the development of clinical diabetes mellitus and suggesting a continuum of risk versus a dichotomy. Third, our sample of Hispanic/Latino adults is inclusive of Hispanic/ Latino background subgroups not previously studied, thereby enhancing the generalizability to US Hispanics.
The current findings in ECHO-SOL provide the first assessment of DD among Hispanics/Latinos with diabetes mellitus and reveal several noteworthy abnormalities. Measures of E/E′ lateral and septal ratios and lateral and septal peak E′ velocities were all worse in prediabetes and diabetes mellitus. In accordance, the odds of DD were increased in prediabetes and diabetes mellitus. Similarly, individuals with uncontrolled diabetes mellitus (versus controlled diabetes mellitus) had less favorable values for several LVDD measures, including an ≈2-fold higher odds of LVDD and a decreasing end-diastolic pressure-volume relationship, denoting an increasing LV stiffness. These data support the notion that worsened measures of cardiac structure (greater LVM) with normal systolic function (ESV) previously observed among Hispanics 6 might be caused by a diabetic cardiomyopathy that is more predominantly defined by greater ventricular stiffness and DD.
Consistent with several previous reports from both the United States and Europe, 4, 6, [20] [21] [22] [23] [24] we also found that relative to diabetes mellitus-free individuals, those with diabetes mellitus or prediabetes had worse measures of cardiac structure, including increased interventricular septum and LVPWd thickness, despite modest increases in LVM. This latter finding for LVM is consistent with results from the previous studies that have found LVM to be higher among groups with glucose intolerance, 4, 6, 22, 23 reinforcing the notion that alterations in cardiac structure and function begin even in prediabetes before overt clinical dysglycemia.
Our study is one of the first studies to assess the impact of diabetes mellitus on cardiac geometry. We found that those with diabetes mellitus or prediabetes had greater RWT and increased odds of abnormal LV geometry. Our findings that stroke volume was decreased in diabetes mellitus, and EDV was lower in prediabetes and diabetes mellitus, contrast with results from MESA. In MESA, no association was reported between diabetes mellitus status and either EDV or stroke volume (although subgroup analyses showed the findings in men to be consistent with our results). 6 Neither diabetes mellitus nor prediabetes were associated with fractional shortening in ECHO-SOL, which is consistent with cardiovascular health study results 20 but conflicts with strong heart study results, in which modestly reduced fractional shortening was observed in diabetes mellitus. 4 However, the generally weak relationships between diabetes mellitus status and measures of systolic function are consistent with the notion that diabetic cardiomyopathy among Hispanics/Latinos is predominantly driven by DD. The fact that several outcomes were less favorable among prediabetics, although to a lesser degree, is consistent with results from at least 3 other samples 6, 20, 23, 24 and further demonstrates that subtle cardiac abnormalities likely begin early in the natural history of diabetogenesis and before the manifestation of clinically abnormal glucose values. This is also supported by longitudinal results from the MONICA/KORA study (Monitoring Trends and Determinations in Cardiovascular Diseases/Cooperative Research in the Region of Augsburg), which demonstrate worsened cardiac structural and functional longitudinal changes among initially diabetes mellitus-free individuals who develop diabetes mellitus longitudinally. 24 From a clinical perspective, this finding may indicate value in risk stratification algorithms to incorporate early indicators of glucose intolerance.
Few previous studies have compared echocardiographic parameters between controlled and uncontrolled diabetes mellitus. We observed that several echocardiographic parameters were worse among those with uncontrolled diabetes mellitus. Whether aggressive glucose-lowering therapy can prevent these cardiac alterations remains unknown, but it supports the notion that HbA1c <7% may be important for cardiac health.
To our knowledge, this is the first report to investigate the association between insulin resistance and cardiac structure and function among Hispanic/Latinos. As with results for prediabetes, the observation that insulin resistance is associated with echocardiographic parameters suggests that the pathophysiology linking diabetes mellitus to HF risk might begin early in the natural history of diabetogenesis. Patterns observed for insulin resistance were generally unchanged even when restricted to individuals with or without diabetes mellitus, suggesting mechanisms independent of hyperglycemia.
The observation that measures of diastolic function were consistently worsened among groups with prediabetes, uncontrolled diabetes mellitus, or insulin resistance is consistent with results from the previous studies of diastolic HF in the context of diabetic cardiomyopathy. 25, 26 In particular, our EDV20 findings indicate that LV compliance during diastole is reduced among individuals with prediabetes/diabetes mellitus and among uncontrolled diabetes mellitus and along a gradient of increasing insulin resistance. These results hint that this relationship potentially exists across a broad spectrum of glucose intolerance extending into clinically normal glucose ranges. Moreover, we also observed increased prevalence of DD in the presence of diabetes mellitus or elevated insulin resistance. These findings are of particular relevance, given the contemporary challenge posed by HF with preserved EF (HFpEF). Although HFpEF now accounts for 50% of HF cases and has similarly poor outcomes compared with HF with reduced EF, there is limited knowledge about the pathophysiology of HFpEF, and effective treatments for HFpEF remain elusive. 27 However, our findings of lower left atrial volume indexed values are unexpected and seemingly contradictory to our other findings. One explanation is that our findings of structural and functional abnormalities are early in their time course in this relatively young cohort. Because left atrial volume index serves as a barometer of cumulative exposure to these structural and functional abnormalities, it is possible that over time left atrial volume index will increase on future sequential echocardiographic examinations. Furthermore, others recently have noted reduced left atrial volume indexed to body surface area in diabetes mellitus, 28 which may reflect overcorrection by indexing to body surface area in obese patients. Future studies, including ongoing longitudinal echocardiographic reassessments in ECHO-SOL 2, will help to inform the natural progression of left atrial parameters vis-à-vis glucose homeostasis specifically and to evaluate whether diabetic cardiomyopathy has a unique underlying pathophysiology among Hispanics/Latinos who might predispose to HFpEF.
The magnitudes of our observed associations are modest, limiting the short-term clinical relevance of these findings. However, the long-term public health importance is likely high, given the potential for the accumulation of cardiac damage during the life course. This possibility is particularly salient given the high diabetes mellitus prevalence among Hispanics/Latinos 11, 29, 30 coupled with the fact that cardiac dysfunction is an independent risk factor for the future development of clinical HF. 5, [31] [32] [33] [34] [35] Some limitations should be noted. These data are crosssectional in nature, limiting temporal inference, although it is unlikely that the generally modest levels of cardiac structural and functional abnormalities contributed meaningfully to the diabetic or prediabetic state, thus modestly strengthening temporal inference. We did not distinguish between T1DM and T2DM, and it is possible that different diabetes mellitus types are differentially related to cardiomyopathy. Given the extremely low prevalence of T1DM (<1% among Hispanics), it is likely that the present findings largely reflect T2DM. Diabetes mellitus status was confirmed based on 1 encounter and without repeated testing, possibly causing some misclassification; however, this measurement error would have likely biased results toward the null. Relationship between quintiles of homeostatic model assessment for insulin resistance (HOMA-IR) and measures of diastolic function, including E/E′ lateral and septal ratios (A), lateral peak and medial peak E′ velocities (B), prevalent diastolic dysfunction (C), and (D) predicted end-diastolic volume at an end-diastolic pressure of 20 mm Hg. Adjusted for age, sex, site, smoking status, alcohol use, physical activity, body mass index, hypertension and chronic kidney disease. The scaling is based on the clinically meaningful ranges. Zero was not included in the scale because a value of zero is not biologically plausible.
Finally, although the prevalence of systolic dysfunction was low, possibly limiting our power to detect associations, we used the most recent recommended volumetric methodology for assessing LVEF; however, LVEF may not be as sensitive a measure, and possibly using speckle-tracking echocardiography in future studies will provide further insight.
The aforementioned weaknesses are counterbalanced by notable strengths. Our ECHO-SOL sample provides the largest data set of echocardiographic parameters to date focused solely on US Hispanics/Latinos and is inclusive of the previously under-represented Hispanic/Latino background groups; ECHO-SOL represents both the overall HCHS/SOL sample and the Hispanic/Latino background group distribution found in each HCHS/SOL field center, thus heightening generalizability. Our inclusion of robust diastolic function assessments informs the evolving understanding of diabetic cardiomyopathy and justifies future mechanistic and interventional investigations relevant to diastolic function. Finally, we have considered whether insulin resistance, a key pathology in the early natural history of diabetogenesis, is related to cardiac structure and function among diabetes mellitus-free Hispanics.
We have found prediabetes, controlled diabetes mellitus, uncontrolled diabetes mellitus, and insulin resistance to be associated with modest differences in several measures of cardiac structure and function in a population-based sample of Hispanic/Latino men and women. Findings were generally stronger for the measures of diastolic function but were nevertheless present for the measures of cardiac structure and largely consistent with results from non-Hispanic study samples. However, the generally weak relationships between diabetes mellitus status and measures of systolic function are consistent with the notion that diabetic cardiomyopathy among Hispanics/Latinos may predominantly manifest as DD. The observed associations were consistent after multivariable adjustment for confounders, including measures of adiposity, hypertension, and health behaviors. Longitudinal follow-up of the ECHO-SOL cohort is necessary to determine whether these modest associations translate in better prediction of clinically relevant outcomes, including incident HF and mortality. If so, these results would have high public health importance given the fact that Hispanics have high rates of T2DM (diagnosed and undiagnosed), 29, 30 coupled with the fact that Hispanics are expected to account for 25% of the US population by 2050, and little is known about the interplay between glucose homeostasis, insulin resistance, and cardiac abnormalities.
